Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleGilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia.AuthorsMori, Masamichi; Kaneko, Naoki; Ueno, Yoko; Yamada, Masaki; Tanaka, Ruriko; Saito, Rika; Shimada, Itsuro; Mori, Kenichi; Kuromitsu, SadaoPublicationInvestigational New Drugs, 2017, Vol 35, Issue 5, p556ISSN0167-6997Publication typeArticleDOI10.1007/s10637-017-0470-z